Helsinki University Hospital

Running trials

• Not yet recruiting

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· Phase 3· Boehringer Ingelheim· Source

• Not yet recruiting

  A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment

  NCT07926321· Phase 2· Boehringer Ingelheim· Source

• Not yet recruiting

  Randomized Clinical Trial for Tonsil Surgery in Adults With Obstructive Sleep Apnea and Enlarged Tonsils

  NCT07580170· Turku University Hospital· Source

• Recruiting

  Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

  NCT05936580· Phase 4· Octapharma· Source

• Recruiting

  A 2-part Phase 1/2 Open-label Trial on ODM-212

  NCT07563738· Phase 1/2· Orion Corporation, Orion Pharma· Source

• Recruiting

  Execise Intervention in Adult Severe Asthma

  NCT07655037· Helsinki University Central Hospital· Source

• Recruiting

  ListenFuture-Listening for Their Future: Deaf and Hard-of-Hearing Adolescents

  NCT07416292· Heikki Löppönen· Source

• Recruiting

  Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer

  NCT07331519· Oulu University Hospital· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Recruiting

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  NCT06841354· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial

  2024-513092-40-00· Phase 4· Stichting Radboud universitair medisch centrum· Source

• Recruiting

  Fascial Manipulation in Cerebral Palsy Rehabilitation

  NCT06837025· Orton Orthopaedic Hospital· Source

• Recruiting

  HFPEF-project: Heart Failure Phenotyping - Exploring the Fingerprints

  NCT06465043· University of Helsinki· Source

• Recruiting

  Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

  NCT06218875· W.L.Gore & Associates· Source

• Recruiting

  PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

  NCT06033131· Phase 3· Lina Bergman· Source

• Recruiting

  Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer

  NCT06310759· Tampere University Hospital· Source

• Recruiting

  Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study

  NCT05935358· Phase 4· Octapharma· Source

• Recruiting

  Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries

  NCT05849857· Phase 2· Oslo University Hospital· Source

• Active, not recruiting

  Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  NCT05701358· Population Health Research Institute· Source

• Recruiting

  Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

  NCT05589714· Jaeb Center for Health Research· Source

• Recruiting

  Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD

  NCT04433052· Tampere University· Source

• Recruiting

  Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis

  NCT05278520· University of Turku· Source

• Recruiting

  Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

  NCT05378347· Medtronic Cardiovascular· Source

• Active, not recruiting

  The Helsinki Unruptured Intracranial Aneurysm Quality of Care Study

  NCT06147102· Helsinki University Central Hospital· Source

• Recruiting

  Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

  NCT05732623· San Raffaele University· Source

• Active, not recruiting

  SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines

  NCT04705389· University Hospital, Tours· Source

• Recruiting

  Sleep and Neuropathic Pain - Intervention Study on Pregabalin

  NCT06155916· Helsinki University Central Hospital· Source

• Recruiting

  Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

  NCT05448547· Phase 3· Sven Löffeler· Source

• Active, not recruiting

  Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study

  NCT05607745· University of Eastern Finland· Source

• Recruiting

  Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery

  NCT05245877· Phase 4· Helsinki University Central Hospital· Source

• Active, not recruiting

  Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

  NCT05069558· Occlutech International AB· Source

• Recruiting

  PErsonalized TReatment for Endometrial Carcinoma

  NCT05655260· University of Helsinki· Source

• Active, not recruiting

  Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

  NCT05446779· Helsinki University Central Hospital· Source

• Recruiting

  Systems Oncology Approach to Optimize Ovarian Cancer Treatment

  NCT06117384· University of Helsinki· Source

• Active, not recruiting

  EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke

  NCT05029414· University Hospital, Basel, Switzerland· Source

• Recruiting

  MYTHS - MYocarditis THerapy With Steroids

  NCT05150704· Phase 3· Niguarda Hospital· Source

• Active, not recruiting

  SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

  NCT04722250· Medtronic Cardiovascular· Source

• Recruiting

  Pre- Vs Postoperative Thromboprophylaxis for Liver Resection

  NCT04731558· Phase 4· Helsinki University Central Hospital· Source

• Active, not recruiting

  International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular Approach

  NCT04572230· Stryker Neurovascular· Source

• Recruiting

  Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma

  NCT04651530· Helsinki University Central Hospital· Source

• Active, not recruiting

  Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

  NCT04603001· Phase 1· Eli Lilly and Company· Source

• Recruiting

  Comparison Of iStent to Laser in Exfoliation Glaucoma Helsinki Study Group

  NCT04635020· Helsinki University Central Hospital· Source

• Active, not recruiting

  Supramarginal Resection in Glioblastoma

  NCT04243005· St. Olavs Hospital· Source

• Active, not recruiting

  SAPIEN 3 Ultra System PMCF

  NCT04555967· Edwards Lifesciences· Source

• Active, not recruiting

  Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery

  NCT04281667· Phase 4· Helsinki University Central Hospital· Source

• Active, not recruiting

  Rate of Progression in EYS Related Retinal Degeneration

  NCT04127006· Jaeb Center for Health Research· Source

• Recruiting

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  NCT04221035· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Active, not recruiting

  LITMUS Imaging Study

  NCT05479721· University of Oxford· Source

Showing 50 of 63.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• Heart failure3 recruiting
• Obesity3 recruiting
• Prostate cancer3 recruiting
• Aortic aneurysm2 recruiting
• Glaucoma2 recruiting
• Haemophilia2 recruiting
• High blood pressure2 recruiting
• Liver and biliary tract cancer2 recruiting
• Lung cancer2 recruiting
• Pancreatic cancer2 recruiting
• Stroke2 recruiting
• Asthma1 recruiting
• Atrial fibrillation1 recruiting
• Bladder cancer1 recruiting
• Bronchiectasis1 recruiting
• Cerebral palsy1 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Endometrial cancer1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Follicular lymphoma1 recruiting
• Hearing loss1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Insomnia1 recruiting
• Liver cirrhosis1 recruiting
• Mesothelioma1 recruiting
• Myocarditis1 recruiting
• Neuroblastoma1 recruiting
• Obstructive sleep apnoea1 recruiting
• Osteoarthritis1 recruiting
• Ovarian cancer1 recruiting
• Retinitis pigmentosa1 recruiting
• Rheumatoid arthritis1 recruiting
• Triple-negative breast cancer1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Terminated

  A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

  NCT06215755· Phase 1· Verge Genomics· Source

• Completed

  Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

  NCT05499832· Phase 3· Insel Gruppe AG, University Hospital Bern· Source

• Completed

  Neuropsychological Rehabilitation Over the Internet

  NCT05413733· Helsinki University Central Hospital· Source

• Completed

  The Effects of Videogames on Depression Symptoms and Brain Dynamics

  NCT05426265· Aalto University· Source

• Completed

  Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)

  NCT04823585· Phase 4· Helsinki University Central Hospital· Source

• Completed

  SAPIEN 3 Ultra EU PMS

  NCT04860752· Edwards Lifesciences· Source

• Completed

  Improvement of Care of Patients Undergoing Pancreaticoduodenectomy

  NCT04668781· Helsinki University Central Hospital· Source

• Completed

  Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)

  NCT04223791· Phase 3· Merck Sharp & Dohme LLC· Source

• Completed

  Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia

  NCT03979014· Phase 3· Imperial College London· Source

• Completed

  Pre-eclampsia and Future Cardiovascular Health: An Underused Opportunity to Improve Family Health

  NCT04676295· Helsinki University Central Hospital· Source

• Completed

  Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)

  NCT03704415· Helsinki University Central Hospital· Source

• Withdrawn

  Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage?

  NCT03358095· Helsinki University Central Hospital· Source

• Withdrawn

  Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?

  NCT03350763· Helsinki University Central Hospital· Source

• Completed

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· Phase 3· German CLL Study Group· Source

• Completed

  A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

  NCT02615691· Phase 3· Baxalta now part of Shire· Source

• Recruiting

  Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

  NCT03256240· Weill Medical College of Cornell University· Source

• Recruiting

  ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis

  NCT01301885· Turku University Hospital· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke132 works · 8 trials
• Type 1 diabetes44 works · 0 trials
• Acute myeloid leukaemia23 works · 1 trial
• Brain aneurysm16 works · 2 trials
• Meningioma12 works · 0 trials
• Coeliac disease10 works · 0 trials
• Cerebral palsy9 works · 1 trial
• Myelodysplastic syndromes9 works · 1 trial
• Peripheral artery disease9 works · 0 trials
• Cytomegalovirus infection8 works · 0 trials
• Hydrocephalus7 works · 0 trials
• Haemophilia7 works · 3 trials
• Sarcoidosis6 works · 0 trials
• Lyme disease4 works · 0 trials